In the fast-evolving Life Sciences industry, there’s a pressing need to accelerate go-to-market and increase agility in producing vaccines, medicines, and therapies. As a trusted partner for biotech, biopharma, and pharma companies, Actemium supports this trend with a unique combination of multi-tech solutions and a multi-country approach. 

Our Know-How

At Actemium, we help transform production facilities into the digital enterprises of the future. We offer expertise in improving efficiency and cost savings through IoT and AI integration, enhancing data integrity and ensuring cybersecurity. Our multi-technical solutions include HVAC, EMS, robotics, and tailored process solutions. We also provide comprehensive quality assurance and long-term support, ensuring your facilities meet the highest standards. 

Our Solutions

We offer a range of solutions to enhance the Life Sciences sector. Our Alarm Management System (AMS) consolidates plant alarms for better oversight. Actemium specialises in automation, from Industry 4.0 and MES/MOM to data management and industrial IT. Our building solutions include clean rooms, EMS, BMS, and HVAC. Additionally, our experts excel in logistics and packaging, providing serialisation, robotics, and warehouse management systems. Actemium process expertise covers clean and black utilities, modular skids, and comprehensive validation services to ensure compliance and efficiency across your operations. 

Connect with Actemium's Experts

If you have questions or want to acces to our service click here!

News

06/02/2024 Data Science

Gene Therapy Advancements: Actemium Boosts Pharmatech Growth

Yposkesi is one of Europe's largest Contract Development and Manufacturing Organizations for gene therapy viral vector manufacturing.
Read more
Data Science

Boosting industrial process with data science and machine learning!

The Syngenta plant in Saint Pierre la Garenne, which is specialized in producing seeds and phytosanitary products for farmers, was looking to optimize its industrial performance.
Read more

Go back to segments